Gottlieb’s job one
Commentary: How Gottlieb needs to transform regulatory science at FDA
Four decades ago, in the aftermath of a narrowly avoided public health disaster, Bob Temple and a handful of his colleagues at FDA led a regulatory revolution. In the course of figuring out how to implement legislation Congress had passed in response to the thalidomide tragedy a decade before, Temple helped define how drug companies could comply with the law’s requirement to conduct pre-market “adequate and well-controlled trials.”
FDA’s regulations for demonstrating safety and efficacy transformed the way drugs were developed. The requirements the agency crafted, including for prespecified experimental and statistical protocols, propelled a scientific and medical revolution. The need to pass rigorous tests for scientific truth made it possible for the first time in history to confidently distinguish medicine from quackery...
BCIQ Company Profiles